Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 125, 2005 - Issue 4
Submit an article Journal homepage
62
Views
14
CrossRef citations to date
0
Altmetric
Original Article: Oncology

Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer

Toshirou Kawano Department of Otorhinolaryngology, Hiratsuka Kyousai Hospital, Kanagawa, JapanCorrespondence[email protected]
,
Shunsuke Yanoma Research Institute, Kanagawa Cancer Center, Yokohama, Japan
,
Yoshiyasu Nakamura Research Institute, Kanagawa Cancer Center, Yokohama, Japan
,
Akemi Ozeki Department of Otorhinolaryngology, Hiratsuka Kyousai Hospital, Kanagawa, Japan
,
Toshiyuki Kokatsu Department of Otorhinolaryngology, Hiratsuka Kyousai Hospital, Kanagawa, Japan
,
Akira Kubota Research Institute, Kanagawa Cancer Center, Yokohama, Japan
,
Madoka Furukawa Research Institute, Kanagawa Cancer Center, Yokohama, Japan
&
Mamoru Tsukuda Department of Otorhinolaryngology, Yokohama City University School of Medicine, Yokohama, Japan
 show all
Pages 392-397 | Received 27 Apr 2004, Accepted 24 Aug 2004, Published online: 08 Jul 2009

References

  • Jalkanen S, Wu N, Bargatze RF, Butcher EC. Human lymphocyte and lymphoma homing receptors. Ann Rev Med 1987;38:467–76.
  • Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61: 1303–13.
  • Shimizu Y, Van Seventer GA, Siraganian R, Wahl L, Shaw S. Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 1989;143:2457–63.
  • Jalkanen S, Bargatze RF, de Los Toyos J, Butcher EC. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95kd glycoprotein antigen differ-entially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells. J Cell Biol 1987;105: 983–90.
  • Haynes BF, Telen MJ, Hale LP, Dennings SM. CD44, a molecule involved in leukocyte adherence and T-cell activa-tion. Immunol Today 1989;10:423–8.
  • Miyake K, Medina KL, Hayashi S, Ono S, Hamaoka T, Kincade PW. Monoclonal antibodies to pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 1990;171:477–88.
  • Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A. CD44 contributes to T cell activation. J Immunol 1989;143:798–801.
  • Denning SM, Le PT, Singer KH, Haynes BF. Antibodies against the CD44 p80, lymphocyte homing receptor mole-cule augment human peripheral blood T cell activation. J Immunol 1990;144:7–15.
  • Mulder JW, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, et al. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994;344:1470 —2.
  • Kainz C, Kohlberger P, Tempfer C, Sliutz G, Gitsch G, Reinthaller A, et al. Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer 1995;31A: 1706–9.
  • Kuppner MC, Van Meir E, Gauthier T, Hamou MF, de Tribolet N. Differential expression of the CD44 molecules in human brain tumors. hit J Cancer 1992;50:572–7.
  • Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 1992;89: 12160–4.
  • Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995;345: 615–9.
  • Sinn HP, Heider KH, Skroch-Angel P, von Minckwitz G, Kaufmann M, Herrlich P, et al. Human mammary carcino-mas express homologues of metastasis-associated variants of CD44. Breast Cancer Res Treat 1995;36: 307–13.
  • Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 1993; 120:227–33.
  • Heider KH, Dammrich J, Skroch-Angel P, Muller-Herme-link HK, Vollmers HP, Herrlich P, et al. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993;53: 4197–203.
  • Wielenga VJM, Heider KH, Offerhaus GJA, Adolf GR, van den Berg FM, Ponta H, et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993;53:4754–6.
  • Pals ST, Koopman G, Heider KH, Griffioen A, Adolf GR, Van den Berg F, et al. CD44 splice variants: expression during lymphocyte activation and tumor progression. Behr-ing Inst Mitt 1993;92: 273–7.
  • Koopman G, Heider KH, Horst E, Adolf GR, Van den Berg F, Ponta H, et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993;177:897–904.
  • Dalchau R, Kirkley J, Fabre JW. Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat. Eur J Immunol 1980;10: 745–9.
  • Carolin L, Renate M, Thomas B, Martie WT, Hellmut S, Andrea B, et al. Soluble CD44v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44v5 and v6 variants in primary tumors and location of distant metastasis. Breast Cancer Res Treat 1998;47: 29–40.
  • Kawano T, Nakamura Y, Yanoma S, Kubota A, Furukawa M, Tsukuda M, et al. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx 2004;31:35–41.
  • Ristamaki R, Joensuu H, Salmi M, Jalkanen S. Serum CD44 in malignant lymphoma: an association with treatment response. Blood 1994;84:238–43.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.